<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04717037</url>
  </required_header>
  <id_info>
    <org_study_id>RJ20/109/J</org_study_id>
    <nct_id>NCT04717037</nct_id>
  </id_info>
  <brief_title>Olive Oil Massage Effect for Reduction of Preterm Sepsis (OMEPS)</brief_title>
  <acronym>OMEPS</acronym>
  <official_title>Olive Oil Massage Effect for Reduction of Preterm Sepsis (OMEPS), Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King Abdullah International Medical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>King Abdulaziz University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King Abdullah International Medical Research Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The OMEPS trial is a randomized clinical trial in the western region of Saudi Arabia.&#xD;
      Conducted to assess the safety and feasibility of olive oil as massage for preterm infants&#xD;
      and if associated with reduced risk of Late-Onset sepsis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of culture-proven sepsis in the blood or CSF</measure>
    <time_frame>72 hours from birth till 28 days of life</time_frame>
    <description>Primary outcomes defined as the rate of culture-proven sepsis in the blood or CSF in the 28 days of life.Late-onset sepsis defined as sepsis onset after 72 h of life.&#xD;
The olive oil will be applied initially at 72 hours of life then twice daily with a dose of 4ml/kg.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neonatal Skin Condition score</measure>
    <time_frame>72 hours from birth till 28 days of life</time_frame>
    <description>Validated Scoring system [ Neonatal Skin Condition Score ] will be used to score the skin integrity, and care will be monitored at baseline then weekly till age 28th of life or discharge.&#xD;
Skin condition was assessed with the Neonatal Skin Condition Score,This score has 9 scores from 1 to 9, 1 depicting the best skin state and 9 the worst with erythema, blistering &amp; oozing over the entire area.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Sepsis</condition>
  <condition>Pre-Term</condition>
  <condition>Late-Onset Neonatal Sepsis</condition>
  <arm_group>
    <arm_group_label>Study</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The olive oil massage will be applied initially at 72 hrs of life then twice daily with a dose of 4ml/kg till 28 days .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients who are assigned to the control group will receive standard care as per unit policies.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Olive Oil Massage</intervention_name>
    <description>olive oil massage application.</description>
    <arm_group_label>Study</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Preterm infants born at one of the participated centers.&#xD;
&#xD;
          2. Preterm Infants born at ≥24weeks gestation and ≤32weeks gestation&#xD;
&#xD;
          3. Birth weight ≥ 500gm up to 2000 gm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Outborn Infants.&#xD;
&#xD;
          2. Preterm infants &lt; 24wk or &gt; 32 wk&#xD;
&#xD;
          3. Preterm infants &lt; 500 gm or &gt; 2000gm&#xD;
&#xD;
          4. Critically ill patients, e.g., Hemodynamic unstable, culture-confirmed neonatal&#xD;
             sepsis, Hydrops fetalis, Life-threatening congenital anomalies.&#xD;
&#xD;
          5. Congenital skin anomalies or infection&#xD;
&#xD;
          6. Major surgical procedure&#xD;
&#xD;
          7. Any patient whose parents refuse consent.&#xD;
&#xD;
          8. Death within 48 hours of life.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>24 Weeks</minimum_age>
    <maximum_age>32 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jubara Alallah</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Abdulaziz Medical city , WR</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jubara Alallah</last_name>
    <phone>966554688775</phone>
    <phone_ext>28335</phone_ext>
    <email>AlallahJS@ngha.med.sa</email>
  </overall_contact>
  <location>
    <facility>
      <name>King Abdulaziz Medical City</name>
      <address>
        <city>Jeddah</city>
        <state>WR</state>
        <zip>21423</zip>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jubara Alallah, MD</last_name>
      <phone>0122266666</phone>
      <phone_ext>22069</phone_ext>
      <email>alallahjs@ngha.med.sa</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>King Abdulaziz University Hospital</name>
      <address>
        <city>Jeddah</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Saad Alsaedi</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>December 8, 2020</study_first_submitted>
  <study_first_submitted_qc>January 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 20, 2021</study_first_posted>
  <last_update_submitted>January 18, 2021</last_update_submitted>
  <last_update_submitted_qc>January 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Olive oil</keyword>
  <keyword>Massage</keyword>
  <keyword>Preterm</keyword>
  <keyword>Late-Onset sepsis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Neonatal Sepsis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

